rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-5-27
|
pubmed:abstractText |
The carbonic anhydrase inhibitor methazolamide infrequently causes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). An association between these diseases and the HLA-B59 serotype has been suggested in case reports. This study examined the disease-associated B*59 allele and investigated the association of these diseases with other HLA class I alleles.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1744-8042
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
879-84
|
pubmed:meshHeading |
pubmed-meshheading:20504258-Adult,
pubmed-meshheading:20504258-Alleles,
pubmed-meshheading:20504258-Epidermal Necrolysis, Toxic,
pubmed-meshheading:20504258-Female,
pubmed-meshheading:20504258-Genotype,
pubmed-meshheading:20504258-HLA-B Antigens,
pubmed-meshheading:20504258-Humans,
pubmed-meshheading:20504258-Male,
pubmed-meshheading:20504258-Methazolamide,
pubmed-meshheading:20504258-Middle Aged,
pubmed-meshheading:20504258-Republic of Korea,
pubmed-meshheading:20504258-Stevens-Johnson Syndrome
|
pubmed:year |
2010
|
pubmed:articleTitle |
HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
|
pubmed:affiliation |
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|